J&J and Medtronic presented their findings at the Asia Pacific Heart Rhythm Society meeting in Busan, South Korea.
Medtronic continues to strengthen its position in cardiac ablation, building on a legacy of innovation in electrophysiology ...
ROCHESTER, NY, UNITED STATES, October 22, 2026 /EINPresswire.com/ -- As medical device manufacturers advance new ...
Johnson & Johnson reports first real-world VARIPULSE Pro Platform data and 12-Month OMNYPULSE Platform outcomes for atrial fibrillation treatment ...
Medtronic plc announced positive real-world registry results for the Affera Mapping and Ablation System with the Sphere-9? Catheter and the PulseSelect Pulsed Field Ablation (PFA) System. The global ...
Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced the first ...
Medtronic ( MDT) reported positive results from two large real-world registries evaluating its Sphere-9 Catheter and the PulseSelect Pulsed Field Ablation (PFA) System in patients with heart rhythm ...
Abbott plans to spin off its $8.5B Nutrition business by 2027 while cutting its 2026 sales growth outlook amid diabetes pricing and electrophysiology challenges.
Boston Scientific faces slowing growth, recalls, and rising competition. Read here for a detailed investment analysis of BSX ...
HealthDay on MSN
Early rhythm control beneficial for patients with A-Fib, stroke
For patients with atrial fibrillation (AF) and acute ischemic stroke, early initiation of rhythm control is associated with a ...
Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the ...
Key Takeaways The Ohio State University Wexner Medical Center is the first in the Midwest to treat a patient in a trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results